Patents Examined by Trevor Love
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10894017
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: January 19, 2021
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10894018
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: January 19, 2021
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
    Patent number: 10888534
    Abstract: A sterile, sulfite-free aqueous norepinephrine solution comprising up to about 0.2 mg/ml of norepinephrine concentration (as free base), a tonicity adjusting agent, at a pH where the norepinephrine is soluble which is packaged in a flexible plastic container, characterized by being storage stable for from about 12 months to about 24 months at room temperature of about 25° C.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: January 12, 2021
    Assignee: InfoRLife SA
    Inventors: Sergio Dusci, Sayan Dusci
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10874614
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 29, 2020
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Biodegradable polymer microsphere compositions for parenteral administration
    Patent number: 10874612
    Abstract: Novel microsphere compositions for use in parenteral formulations are provided. The microspheres comprise a biodegradable polymer of a molecular weight greater than 10,000 daltons, an active therapeutic agent, and a cellulose-derived material such as ethyl cellulose, carboxymethyl cellulose, hydroxypropylmethyl cellulose, or sodium carboxymethyl cellulose. The microsphere compositions decreased deviation in mean microsphere diameter, improved drug entrapment, and improved microsphere stability.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: December 29, 2020
    Assignee: Adare Pharmaceuticals USA, Inc.
    Inventors: Nathan Dormer, Cory Berkland
  • Residual disinfectant composition
    Patent number: 10874100
    Abstract: A disinfectant composition that is capable of inactivating non-enveloped viruses as well as other microorganisms, such as gram negative and gram positive bacteria, fungi, parasites, enveloped viruses, etc., is provided. Through selective control over the nature of the acid(s) employed and the overall pH level, the present inventors have discovered that the composition can achieve rapid antiviral efficacy, particularly against non-enveloped viruses. Once applied to a surface (e.g., hard surface), the disinfectant composition forms a film that remains capable of providing residual antiviral activity. Notably, the present inventors have discovered that the use of a vinylpyrrolidone copolymer in combination with a polyquaternary ammonium polymer and cationic surfactant can have a synergistic effect on the stability of the film such that it can also achieve long-term, residual antiviral activity.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: December 29, 2020
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Amy L. Vanden Heuvel, Douglas R. Hoffman, Jeremy D. Paulsen, Rebecca Vongsa, Paige N. Anunson, Lisa M. Kroll, Corey T. Cunnington, David W. Koenig
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10874613
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 29, 2020
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Soderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10869837
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 22, 2020
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10869836
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 22, 2020
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Device comprising a liquid lipstick composition in the form of an inverse emulsion, and a porous application member
    Patent number: 10871252
    Abstract: An application device, including a container; a composition for making up and/or caring for the lips (P), stored in the container, which is in the form of a liquid emulsion that includes: a) at least 8% by weight, relative to the total weight of the composition, of one or more non-volatile oils; b) at least one film-forming agent selected from the group consisting of alkylcellulose, silicone resin, and a vinyl polymer comprising a carbosiloxane dendrimer-based unit; c) at least 10% by weight of water relative to the total weight of the composition; and an application member that is suitable for applying the composition which has a porous application surface with one or more open-cell or semi-open cell foams, wherein the composition has a viscosity at 25° C. of between 0.005 and 15 Pa.s.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: December 22, 2020
    Assignee: L'OREAL
    Inventors: Florence Lahousse, Eric Caulier, Emilie Henin, Roberto Cavazzuti
  • Devices and methods for controlling insects
    Patent number: 10856540
    Abstract: Devices and methods for controlling insects are generally described. Typically, the devices include a fiber web comprising a plurality of glass fibers or other substrate made of non-absorptive material impregnated or otherwise loaded with an insect control composition comprising an active insecticidal species (e.g., a pyrethroid such as Transfluthrin). The devices provide protection against arthropods or other insects over prolonged periods of time. Such devices may be lightweight, low-cost, reusable, and disposable, and can be used for both indoor and outdoor purposes.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: December 8, 2020
    Assignee: Novel Textiles & Treatments LLC
    Inventors: Laurie Widder, Gary Innocenti, Sr.
  • Nanoparticles, composition and system for delivering 5FU and uses thereof
    Patent number: 10842756
    Abstract: The present invention relates to nanoparticles of albumin loaded with 5FU and/or with a precursor thereof. Further, the present invention relates to a pharmaceutical composition or a 5FU delivery system and/or a precursor thereof comprising nanoparticles. The present invention also relates to a method for producing said nanoparticles and the use of the nanoparticles, the pharmaceutical composition or the 5FU delivery system and/or a precursor thereof as a medicament, in particular for use in treatment of tumours.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: November 24, 2020
    Assignee: BIOVIIIX S.R.L.
    Inventors: Davide Rosiello, Vincenzo Vigilanza, Salvatore Asero, Matteo Di Minno, Roberta Lupoli
  • Vaporized administration of pesticides
    Patent number: 10834925
    Abstract: The present disclosure relates to methods for administering vaporized pyrimethanil as an antimicrobial to inhibit pathogens of agricultural crops.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: November 17, 2020
    Assignee: AGROFRESH INC.
    Inventors: Richard M. Jacobson, Daniel MacLean, Timothy Malefyt, Esther Gachango
  • Mineral sunscreen compositions with improved efficacy
    Patent number: 10813870
    Abstract: Mineral sunscreen compositions having improved efficacy are described. The mineral sunscreen compositions include: (a) one or more mineral UV filtering agents; (b) one or more stilbenoids; (c) ethylhexylmethoxycrylene. (d) diethylhexyl syringylidenemalonate; and (e) a cosmetically acceptable carrier. The mineral sunscreen compositions provide a high sun protection factor (SPF) without requiring high amounts of mineral UV filtering agents. Also, the mineral sunscreen compositions are less opaque and white than traditional mineral sunscreen compositions making them aesthetically appealing to consumers.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: October 27, 2020
    Assignee: L'OREAL
    Inventors: Anil Shah, Brian Scott Bodnar
  • Cosmetic composition containing organic-inorganic composite particles for blocking near infrared rays
    Patent number: 10806684
    Abstract: Provided is a cosmetic composition including organic-inorganic composite particles for blocking near-infrared rays. When the cosmetic composition for blocking near-infrared rays according to the present disclosure is applied to skin, light in the near-infrared region may be significantly blocked. The cosmetic composition may be used as a multifunctional product in combination with a UV-blocking material to block a wide range of wavelengths adversely affecting the skin, thereby preventing skin aging.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: October 20, 2020
    Assignees: COSMAX INC., IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
    Inventors: Su Ji Kim, Jun Bae Lee, Chun Ho Park, Youn Joon Kim, Kweon Jong Yoo, Myeong Sam Park, Eun Chul Cho, Seong Uk Kim, Min Gyu Kim, Nu Ri Han
  • Ring and tubular structures and methods of synthesis and use thereof
    Patent number: 10799620
    Abstract: Nanofiber structures are provided along with methods of production and methods of use.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: October 13, 2020
    Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
    Inventors: Jingwei Xie, Shixuan Chen, Bernard Timothy Baxter
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10799459
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: October 13, 2020
    Assignee: XSPRAY MICROPARTICLES AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 10786451
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and, optionally, an inhaled corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: September 29, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio Cafiero, Leonardo Ortenzi
  • Nanoparticles for treatment of posterior segment ocular diseases and conditions
    Patent number: 10772843
    Abstract: The present invention concerns nanoparticles useful for treating posterior segment ocular diseases or conditions, such as macular degeneration and diabetic retinopathy; compositions comprising the nanoparticles; methods for producing the nanoparticles; and methods for treating posterior segment ocular diseases or conditions, comprising administering the nanoparticles or compositions to the ocular posterior segment of an afflicted eye.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: September 15, 2020
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Kathleen Emily-Ann Halasz, Yashwant V. Pathak, Vijaykumar Bhadabhai Sutariya
  • Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 10772896
    Abstract: Dry powder formulations for inhalation containing a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: September 15, 2020
    Assignee: CHIESI FARMACEUTICI S.P.A.
    Inventors: Claudio Cafiero, Leonardo Ortenzi, Francesca Schiaretti